Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
Dan Fuglø
Overlæge,Ph.d.
,
Herlev og Gentofte Hospital
,
Nuklearmedicin
https://orcid.org/0000-0002-8926-3549
2011
2025
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikationer
(16)
Lignende profiler
(6)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Dan Fuglø er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Keyphrases
Optic Neuritis
100%
Positron Emission Tomography-computed Tomography (PET-CT)
65%
Multiple Sclerosis
54%
Positron Emission Tomography
53%
Dopamine Synthesis
52%
Functional Magnetic Resonance Imaging
50%
Antipsychotics
50%
Nave
50%
Healthy Controls
50%
Image-derived Input Function
43%
Arterial Input Function
34%
Visual Evoked Potentials
31%
Gjedde-Patlak Plot
31%
First-episode Psychosis
30%
Control Subjects
30%
Treatment Effect
29%
Regressor
26%
Clinical Trials
26%
Inter-scanner
25%
Electroencephalography/functional Magnetic Resonance Imaging
25%
Blood Shift
25%
Retinal Atrophy
25%
Reductase Inhibitors
25%
3-hydroxy-3-methylglutaryl-coenzyme A
25%
18F-fluoride PET
25%
Dopamine D2 Receptor Agonist
25%
Static Apnea
25%
Amyloid Positron Emission Tomography
25%
Coefficient of Variation
25%
Good Manufacturing Practice
25%
GMP Production
25%
L-DOPA
25%
Symptom Response
25%
Potential Therapeutics
25%
Inter-subject Variability
25%
Multimodal Prediction
25%
Non-invasive Quantification
25%
Synthetic Routes
25%
PET Study
25%
Immunomodulatory Effect
25%
Normal Brain
25%
PiB-PET
25%
Glutamate
25%
Therapeutic Implications
25%
Chronic Kidney Disease Stage
25%
Neurotransmitters
25%
Aorta
25%
Fluoro
25%
Blood Oxygenation Level-dependent Response
25%
Breath-hold Divers
25%
Neuroscience
Optic Neuritis
100%
Fluorine-18
78%
Functional Magnetic Resonance Imaging
75%
Multiple Sclerosis
55%
Antipsychotic
50%
Positron Emission Tomography-Computed Tomography
50%
DOPA
41%
Positron Emission Tomography
33%
Psychosis
33%
Visual Evoked Potential
31%
Metabolic Pathway
28%
Nucleus Accumbens
27%
Electroencephalography
25%
Gray Matter
25%
Bohr Effect
25%
Decarboxylation
25%
3 Hydroxy 3 Methylglutaryl Coenzyme A
25%
Simvastatin
25%
Guanosine Monophosphate
25%
Dual-Energy X-Ray Absorptiometry
25%
Ultrasonography
25%
Neurotransmitter
25%
Glutamic Acid
25%
Statin
25%
D2-Receptor Agonists
25%
Skeletal Muscle
25%
Dopamine Receptor D2
25%
Cardiac Magnetic Resonance Imaging
25%
Magnetic Resonance Imaging
25%
Gamma-Aminobutyric Acid
25%
Dopaminergic Activity
25%
Body Mass Index
25%
Cerebellum
16%
Frontal Lobe
16%
Hippocampus
16%
Positron Emission Tomography
16%
Visual Pathway
16%
Positive Syndrome
16%
Anterior Cingulate Cortex
14%
Nerve Fiber
12%
Glutamine Plus Minerals Plus Vitamins
10%
Striatum
8%
Aripiprazole
8%
Negative Syndrome
8%
Putamen
8%
Thalamus
7%
Visual Cortex
6%
Visually Evoked Potential
5%
Congenital Hyperinsulinism
5%
L-DOPA
5%
Medicine and Dentistry
Breathing
50%
Fluorine-18
50%
Apnea
47%
Positron Emission Tomography-Computed Tomography
45%
Positron Emission Tomography
31%
Hypoxia
25%
Blood Oxygenation
25%
Amyloid
25%
Bone Turnover
25%
Functional Magnetic Resonance Imaging
25%
Visual Evoked Potential
25%
Carbon 11
25%
Hemoglobin Determination
25%
Chronic Kidney Disease
25%
Positron Emission Tomography
25%
Prostate Specific Membrane Antigen
25%
Bone Metastasis
25%
Prostate Cancer
25%
Arterial Blood
9%
Echocardiography
8%
Oxygen 15
8%
Bone Mass
6%
Blood Sampling
6%
Non-Invasive Diagnostics
6%
Hemodialysis
6%
Alzheimer's Disease
6%
Parathyroid Hormone
6%
Lumbar Vertebra
6%
Proximal Femur
6%
Diagnostic Procedure
6%
Treatment Effect
6%
Non Invasive Procedure
6%
Spirometry
5%
Visual Stimulation
5%
Volunteer
5%
Visual Cortex
5%
